Tegileridine: First Approval (vol 84, pg 717, 2024)

被引：0

作者：

Dhillon, Sohita ^{[1
]}

机构：

[1] Springer Nat, Private Bag 65901, Mairangi Bay, Auckland 0754, New Zealand

来源：

关键词：

D O I：

10.1007/s40265-024-02079-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1011 / 1011

页数：1

共 50 条

[41] Dinutuximab: First Global Approval (vol 75, pg 923, 2015)
Dhillon, Sohita
DRUGS, 2015, 75 (15) : 1831 - 1831
[42] Decitabine/Cedazuridine: First Approval (vol 80, pg 1373, 2018)
Dhillon, Sohita
DRUGS, 2021, 81 (01) : 179 - 179
[43] Ivosidenib: First Global Approval (vol 78, pg 1509, 2018)
Dhillon, Sohita
DRUGS, 2019, 79 (01) : 107 - 107
[44] Sarecycline: First Global Approval (vol 79, pg 325, 2019)
Deeks, Emma D.
DRUGS, 2019, 79 (07) : 795 - 795
[45] Reslizumab: First Global Approval (vol 76, pg 907, 2016)
Markham, Anthony
DRUGS, 2016, 76 (11) : 1159 - 1159
[46] Valemetostat Tosilate: First Approval (vol 82, pg 1621, 2022)
Keam, Susan J.
DRUGS, 2022, 82 (17) : 1689 - 1689
[47] Nadofaragene Firadenovec: First Approval (vol 83, pg 353, 2023)
Lee, Arnold
DRUGS, 2023, 83 (10) : 951 - 951
[48] Delafloxacin: First Global Approval (vol 77, pg 1481, 2017)
Markham, Anthony
DRUGS, 2018, 78 (15) : 1651 - 1651
[49] Panobinostat: First Global Approval (vol 75, pg 695, 2015)
Garnock-Jones, Karly P.
DRUGS, 2015, 75 (08) : 929 - 929
[50] Idelalisib: First Global Approval (vol 74, pg 1701, 2014)
Markham, Anthony
DRUGS, 2014, 74 (15) : 1839 - 1839